On April 23 the CDC and FDA lifted the pause on the Johnson & Johnson vaccine allowing providers to begin administering the vaccine. The use of the vaccine was paused to review the possible link between the vaccine use and the formation of a rare form of blood clots. These clots were reported in women age 18 to 48 years of age and occurred at a rate of approximately 1 in every 1 million vaccinations. The CDC panel determined that the benefits of being vaccinated with the J & J product outweighed the potential risks associated with the formation of the blood clots. Moving forward, public health will be offering the J&J and Moderna vaccines at all our upcoming clinics.